Brief: Ultimovacs Expands High Dose Cohort Size In Tendu Phase I Prostate Cancer Trial

Zelluna ASA

18/08/2022 07:29

Aug 18 (Reuters) - Ultimovacs ASA  ULTI.OL :
    * REG-ULTIMOVACS EXPANDS HIGH DOSE COHORT SIZE IN TENDU
PHASE I
PROSTATE CANCER TRIAL AFTER SAFETY REVIEW

Source text for Eikon:  ID:nGNE1KXlJk 
Further company coverage:  ULTI.OL 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))